Nascimento Alessandra F, Winters Gayle L, Pinkus Geraldine S
Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.
Am J Surg Pathol. 2007 Sep;31(9):1344-50. doi: 10.1097/PAS.0b013e3180317341.
Primary lymphomas of the heart are rare and frequently are diagnosed at autopsy. Modern imaging technology now permits early diagnosis and treatment. This report describes the clinical, histologic, immunophenotypic, and molecular genetic findings for 5 patients with malignant lymphoma restricted to the cardiac muscle, with or without pericardial involvement. All patients were women, with ages ranging from 40 to 68 years (median 55 y). The right atrium was involved in all cases with the left atrium, right ventricle, and pericardium affected in 1 case each. Clinical presentation included pericardial effusions associated with precordial pain, dyspnea, and bradycardia. Electrocardiographic changes included junctional rhythm, incomplete right bundle branch block and ST and T waves abnormalities, and ST segment elevation and first-degree atrioventricular block with intermittent complete heart block. In all cases, biopsy or resection of the lesion or cytologic examination of the pericardial fluid established a diagnosis. All tumors were of B-cell phenotype and included 4 cases of large cell lymphoma and one unclassifiable small cell lymphoma. In 2 cases, a follicular center cell origin was supported by reactivity of the neoplastic cells for CD10 and bcl-6 and by bcl-2 gene rearrangement by molecular analysis. One patient died shortly after diagnosis due to cerebral infarction. Two patients are alive without disease after chemotherapy with CHOP after 120 and 192 months. One patient underwent chemotherapy with CHOP and rituximab, and shows persistent cardiac involvement by lymphoma but with a decrease in tumor burden at 7 months of follow-up. One patient was lost to follow-up. Clinical outcome is variable; however, early diagnosis in conjunction with effective treatment (surgery and/or chemotherapy) may result in an excellent prognosis. Primary cardiac lymphoma should be included in the differential diagnosis of a right atrial mass.
原发性心脏淋巴瘤较为罕见,常常在尸检时才被诊断出来。现代成像技术如今能够实现早期诊断和治疗。本报告描述了5例局限于心肌、伴或不伴有心包受累的恶性淋巴瘤患者的临床、组织学、免疫表型及分子遗传学特征。所有患者均为女性,年龄在40至68岁之间(中位年龄55岁)。所有病例均累及右心房,1例同时累及左心房、右心室及心包。临床表现包括与心前区疼痛、呼吸困难及心动过缓相关的心包积液。心电图改变包括交界性心律、不完全性右束支传导阻滞以及ST段和T波异常,还有ST段抬高及一度房室传导阻滞伴间歇性完全性心脏传导阻滞。所有病例均通过病变活检或切除或心包积液细胞学检查得以确诊。所有肿瘤均为B细胞表型,包括4例大细胞淋巴瘤和1例无法分类的小细胞淋巴瘤。在2例中,肿瘤细胞对CD10和bcl-6呈反应性以及分子分析显示bcl-2基因重排支持其为滤泡中心细胞起源。1例患者在诊断后不久因脑梗死死亡。2例患者在接受CHOP化疗120个月和192个月后无疾病存活。1例患者接受CHOP和利妥昔单抗化疗,在随访7个月时显示淋巴瘤持续累及心脏,但肿瘤负荷有所减轻。1例患者失访。临床结局各异;然而,早期诊断并结合有效治疗(手术和/或化疗)可能会带来良好的预后。原发性心脏淋巴瘤应纳入右心房肿块的鉴别诊断。